NantHealth, Inc. NH
1.35 +1.35
Day range unavailable
52-week range unavailable
- Analysts
- Buy
- Price target
- 4.00 (+196.3%)
- Earnings date
- May 25, 2023
No chart data for this range yet.
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: buy
Buy
Price target (mean) 4.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
May 25, 2023
Expected May 25, 2023. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 25, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
| Nov 3, 2022 | Sep 1, 2022 | 0.00 | — | — | — |
| Aug 4, 2022 | Jun 1, 2022 | -1.20 | — | — | — |
| May 5, 2022 | Mar 1, 2022 | -1.35 | — | — | — |
| Feb 24, 2022 | Dec 1, 2021 | -1.35 | — | — | — |
News
Travel + Leisure Co. Expands Eddie Bauer Adventure Club with New Trail Partner Network 
NantHealth® Offers New NaviNet® AllPayer Subscription Packages, Now With Electronic Claim Submission 
NantHealth Achieves NCQA Accreditation in Utilization Management 
NantHealth Welcomes Marc Harrison as Chief Legal Officer to Executive Team 
NantHealth Strengthens Product Leadership Team to Drive Innovation in Healthcare Technology 
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session 
Why Bellicum Pharmaceuticals Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket 
Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session 
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session - Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket
Your note
Sign in to keep a note on NH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALLSCRIPTS HEALTHCARE SOLUTIONS INC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jun 6, 2016 | 15,000,000 |
| BLASZYK MICHAEL D | Director | Stock Award(Grant) | Sep 5, 2018 | 148,780 |
| CALHOUN KIRK K | Director | Stock Award(Grant) | Sep 5, 2018 | 148,780 |
| HOLT PAUL ALAN | Chief Financial Officer | Conversion of Exercise of derivative security | Jun 6, 2018 | 64,742 |
| LOUKS RONALD ALLEN | Chief Operating Officer | Sale | Sep 12, 2021 | 225,857 |
| SITRICK MICHAEL S | Director | Stock Award(Grant) | Sep 5, 2018 | 148,780 |